Race Differences in Long-Term Diabetes Management in an HMO
Response to Hart
- Alyce S. Adams, PHD1,
- Fang Zhang, PHD1,
- Connie Mah Trinacty, MS1,
- Richard W. Grant, MD, MPH2,
- Ken Kleinman, SCD1,
- James B. Meigs, MD, MPH2 and
- Dennis Ross-Degnan, SCD1
- 1Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts
- 2General Medicine Unit, Massachusetts General Hospital, Boston, Massachusetts
- Address correspondence to Dr. Alyce S. Adams, PhD, Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, 133 Brookline Ave., 6th Floor, Boston, MA 02215. E-mail: aadams{at}hms.harvard.edu
We read Dr. Hart’s (1) response to our article with great interest. The issue of racial differences in the presence of variant hemoglobins that may affect HbA1c (A1C) test results is certainly an important one. Ours (2) was a retrospective analysis using electronic medical record data that did not contain information on either the presence of sickle hemoglobin or the results of …
